As part of a series on the Average Manufacturer Price (AMP), this month’s article explores the of AMP from the beginning of the Medicaid Drug Rebate Program (MDRP) to where it is today and why there is so much public scrutiny on this once obscure statutory price calculation.
Last month, we explored the origins of Average Manufacturer Price (AMP) and its purpose within the Medicaid Program. AMP is a key component of the Unit Rebate Amount (URA), which is the basis of the quarterly rebate manufacturers pay to states for Medicaid utilization. This month we explore the evolution of AMP from the beginning of the Medicaid Drug Rebate Program (MDRP) to where it is today, and why there is so much public scrutiny on this once obscure statutory price calculation.
Read Full Article in the August 2016 Issue of Life Science Compliance Update